{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T21:40:58Z","timestamp":1763415658271,"version":"3.37.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T00:00:00Z","timestamp":1688774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T00:00:00Z","timestamp":1688774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Calgary Health Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"DOI":"10.1007\/s10554-023-02904-z","type":"journal-article","created":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T07:02:06Z","timestamp":1688799726000},"page":"2005-2014","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Patients with non-ischemic cardiomyopathy and mid-wall striae have similar arrhythmic outcomes as ischemic cardiomyopathy"],"prefix":"10.1007","volume":"39","author":[{"given":"Brennan A.","family":"Ballantyne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bert","family":"Vandenberk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Dykstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina","family":"Labib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek S.","family":"Chew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Lydell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Howarth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bobak","family":"Heydari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nowell","family":"Fine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Howlett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James A.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4676-2433","authenticated-orcid":false,"given":"Robert","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,8]]},"reference":[{"key":"2904_CR1","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1161\/CIRCULATIONAHA.109.192667","volume":"121","author":"D Lloyd-Jones","year":"2010","unstructured":"Lloyd-Jones D, Adams RJ, Brown TM et al (2010) Executive summary: heart disease and stroke statistics-2010 update: a report from the american heart association. Circulation 121:948\u2013954. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.192667","journal-title":"Circulation"},{"key":"2904_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/NRCARDIO.2010.165","volume":"8","author":"AL Bui","year":"2011","unstructured":"Bui AL, Horwich TB, Fonarow GC (2011) Epidemiology and risk profile of heart failure. Nat Rev Cardiol 8:30\u201341. https:\/\/doi.org\/10.1038\/NRCARDIO.2010.165","journal-title":"Nat Rev Cardiol"},{"key":"2904_CR3","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1161\/01.RES.0000145047.14691.DB","volume":"95","author":"GF Tomaselli","year":"2004","unstructured":"Tomaselli GF, Zipes DP (2004) What causes sudden death in heart failure? Circ Res 95:754\u2013763. https:\/\/doi.org\/10.1161\/01.RES.0000145047.14691.DB","journal-title":"Circ Res"},{"key":"2904_CR4","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/J.CJCA.2017.08.022","volume":"33","author":"JA Ezekowitz","year":"2017","unstructured":"Ezekowitz JA, O\u2019Meara E, McDonald MA et al (2017) 2017 Comprehensive Update of the canadian Cardiovascular Society Guidelines for the management of heart failure. Can J Cardiol 33:1342\u20131433. https:\/\/doi.org\/10.1016\/J.CJCA.2017.08.022","journal-title":"Can J Cardiol"},{"key":"2904_CR5","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1016\/J.JACC.2017.10.054","volume":"72","author":"SM Al-Khatib","year":"2018","unstructured":"Al-Khatib SM, Stevenson WG, Ackerman MJ et al (2018) 2017 AHA\/ACC\/HRS Guideline for management of patients with ventricular arrhythmias and the Prevention of Sudden Cardiac death: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 72:e91\u2013e220. https:\/\/doi.org\/10.1016\/J.JACC.2017.10.054","journal-title":"J Am Coll Cardiol"},{"key":"2904_CR6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/EJHF.2333","volume":"24","author":"TA McDonagh","year":"2022","unstructured":"McDonagh TA, Metra M, Adamo M et al (2022) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the heart failure Association (HFA) of the ESC. Eur J Heart Fail 24:4\u2013131. https:\/\/doi.org\/10.1002\/EJHF.2333","journal-title":"Eur J Heart Fail"},{"key":"2904_CR7","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1056\/NEJM199612263352601","volume":"335","author":"AJ Moss","year":"1996","unstructured":"Moss AJ, Hall WJ, Cannom DS et al (1996) Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 335:1933\u20131940. https:\/\/doi.org\/10.1056\/NEJM199612263352601","journal-title":"N Engl J Med"},{"key":"2904_CR8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1056\/NEJM199912163412503","volume":"341","author":"AE Buxton","year":"1999","unstructured":"Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G (1999) A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter unsustained tachycardia trial investigators. N Engl J Med 341:271\u2013273. https:\/\/doi.org\/10.1056\/NEJM199912163412503","journal-title":"N Engl J Med"},{"key":"2904_CR9","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJMOA013474","volume":"346","author":"AJ Moss","year":"2002","unstructured":"Moss AJ, Zareba W, Hall WJ et al (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877\u2013883. https:\/\/doi.org\/10.1056\/NEJMOA013474","journal-title":"N Engl J Med"},{"key":"2904_CR10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1056\/NEJMOA043399","volume":"352","author":"GH Bardy","year":"2005","unstructured":"Bardy GH, Lee KL, Mark DB et al (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352:225\u2013237. https:\/\/doi.org\/10.1056\/NEJMOA043399","journal-title":"N Engl J Med"},{"key":"2904_CR11","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1161\/01.CIR.0000012350.99718.AD","volume":"105","author":"D B\u00e4nsch","year":"2002","unstructured":"B\u00e4nsch D, Antz M, Boczor S et al (2002) Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT). Circulation 105:1453\u20131458. https:\/\/doi.org\/10.1161\/01.CIR.0000012350.99718.AD","journal-title":"Circulation"},{"key":"2904_CR12","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/S0735-1097(03)00297-3","volume":"41","author":"SA Strickberger","year":"2003","unstructured":"Strickberger SA, Hummel JD, Bartlett TG et al (2003) Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia\u2013AMIOVIRT. J Am Coll Cardiol 41:1707\u20131712. https:\/\/doi.org\/10.1016\/S0735-1097(03)00297-3","journal-title":"J Am Coll Cardiol"},{"key":"2904_CR13","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1056\/NEJMOA033088","volume":"350","author":"A Kadish","year":"2004","unstructured":"Kadish A, Dyer A, Daubert JP et al (2004) Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350:2151\u20132158. https:\/\/doi.org\/10.1056\/NEJMOA033088","journal-title":"N Engl J Med"},{"key":"2904_CR14","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1056\/NEJMOA1608029","volume":"375","author":"L K\u00f8ber","year":"2016","unstructured":"K\u00f8ber L, Thune JJ, Nielsen JC et al (2016) Defibrillator Implantation in patients with nonischemic systolic heart failure. N Engl J Med 375:1221\u20131230. https:\/\/doi.org\/10.1056\/NEJMOA1608029","journal-title":"N Engl J Med"},{"key":"2904_CR15","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1056\/NEJMOA050496","volume":"352","author":"JGF Cleland","year":"2005","unstructured":"Cleland JGF, Daubert J-C, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L (2005) The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352:1539\u20131549. https:\/\/doi.org\/10.1056\/NEJMOA050496","journal-title":"N Engl J Med"},{"key":"2904_CR16","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1056\/NEJMOA1409077","volume":"371","author":"JJV McMurray","year":"2014","unstructured":"McMurray JJV, Packer M, Desai AS et al (2014) Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 371:132\u2013133. https:\/\/doi.org\/10.1056\/NEJMOA1409077","journal-title":"N Engl J Med"},{"key":"2904_CR17","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMOA1911303","volume":"381","author":"JJV McMurray","year":"2019","unstructured":"McMurray JJV, Solomon SD, Inzucchi SE et al (2019) Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med 381:1995\u20132008. https:\/\/doi.org\/10.1056\/NEJMOA1911303","journal-title":"N Engl J Med"},{"key":"2904_CR18","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMOA2022190","volume":"383","author":"M Packer","year":"2020","unstructured":"Packer M, Anker SD, Butler J et al (2020) Cardiovascular and renal outcomes with Empagliflozin in Heart failure. N Engl J Med 383:1413\u20131424. https:\/\/doi.org\/10.1056\/NEJMOA2022190","journal-title":"N Engl J Med"},{"key":"2904_CR19","doi-asserted-by":"publisher","unstructured":"Armstrong PW, Pieske B, Anstrom KJ et al (2020) Vericiguat in patients with heart failure and reduced ejection fraction. N Engl J Med 382. https:\/\/doi.org\/10.1056\/NEJMOA1915928","DOI":"10.1056\/NEJMOA1915928"},{"key":"2904_CR20","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/J.CJCA.2020.12.028","volume":"37","author":"RJH Miller","year":"2021","unstructured":"Miller RJH, Howlett JG, Fine NM (2021) A Novel Approach to Medical Management of Heart failure with reduced ejection fraction. Can J Cardiol 37:632\u2013643. https:\/\/doi.org\/10.1016\/J.CJCA.2020.12.028","journal-title":"Can J Cardiol"},{"key":"2904_CR21","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1016\/J.JACC.2008.03.018","volume":"51","author":"KC Wu","year":"2008","unstructured":"Wu KC, Weiss RG, Thiemann DR et al (2008) Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol 51:2414\u20132421. https:\/\/doi.org\/10.1016\/J.JACC.2008.03.018","journal-title":"J Am Coll Cardiol"},{"key":"2904_CR22","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1001\/JAMA.2013.1363","volume":"309","author":"A Gulati","year":"2013","unstructured":"Gulati A, Jabbour A, Ismail TF et al (2013) Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA 309:896\u2013908. https:\/\/doi.org\/10.1001\/JAMA.2013.1363","journal-title":"JAMA"},{"key":"2904_CR23","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1016\/J.JACC.2006.07.049","volume":"48","author":"RG Assomull","year":"2006","unstructured":"Assomull RG, Prasad SK, Lyne J et al (2006) Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 48:1977\u20131985. https:\/\/doi.org\/10.1016\/J.JACC.2006.07.049","journal-title":"J Am Coll Cardiol"},{"key":"2904_CR24","doi-asserted-by":"publisher","unstructured":"Alba AC, Gazta\u00f1aga J, Foroutan F et al (2020) Prognostic value of late Gadolinium Enhancement for the Prediction of Cardiovascular Outcomes in dilated cardiomyopathy: an International, multi-institutional study of the MINICOR Group. Circ Cardiovasc Imaging 13. https:\/\/doi.org\/10.1161\/CIRCIMAGING.119.010105","DOI":"10.1161\/CIRCIMAGING.119.010105"},{"key":"2904_CR25","doi-asserted-by":"publisher","unstructured":"Purmah Y, Cornhill A, Lei LY et al (2022) Mid-wall striae fibrosis predicts heart failure admission, composite heart failure events, and life-threatening arrhythmias in dilated cardiomyopathy. Sci Rep 12. https:\/\/doi.org\/10.1038\/S41598-022-05790-Y","DOI":"10.1038\/S41598-022-05790-Y"},{"key":"2904_CR26","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1161\/CIRCIMAGING.120.011337","volume":"14","author":"Y Purmah","year":"2021","unstructured":"Purmah Y, Lei LY, Dykstra S et al (2021) Right ventricular ejection fraction for the prediction of major adverse Cardiovascular and Heart failure-related events: a Cardiac MRI based study of 7131 patients with known or suspected Cardiovascular Disease. Circ Cardiovasc Imaging 14:224\u2013235. https:\/\/doi.org\/10.1161\/CIRCIMAGING.120.011337","journal-title":"Circ Cardiovasc Imaging"},{"key":"2904_CR27","doi-asserted-by":"publisher","unstructured":"Kawel-Boehm N, Maceira A, Valsangiacomo-Buechel ER et al (2015) Normal values for cardiovascular magnetic resonance in adults and children. J Cardiovasc Magn Reson 17. https:\/\/doi.org\/10.1186\/S12968-015-0111-7","DOI":"10.1186\/S12968-015-0111-7"},{"key":"2904_CR28","doi-asserted-by":"publisher","unstructured":"Schulz-Menger J, Bluemke DA, Bremerich J et al (2013) Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular magnetic resonance (SCMR) board of trustees task force on standardized post processing. J Cardiovasc Magn Reson 15. https:\/\/doi.org\/10.1186\/1532-429X-15-35","DOI":"10.1186\/1532-429X-15-35"},{"key":"2904_CR29","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000156","author":"KA Hicks","year":"2015","unstructured":"Hicks KA, Tcheng JE, Bozkurt B et al (2015) Circulation 132:302\u2013361. https:\/\/doi.org\/10.1161\/CIR.0000000000000156. 2014 ACC\/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards)"},{"key":"2904_CR30","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/SIM.3697","volume":"28","author":"PC Austin","year":"2009","unstructured":"Austin PC (2009) Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med 28:3083\u20133107. https:\/\/doi.org\/10.1002\/SIM.3697","journal-title":"Stat Med"},{"key":"2904_CR31","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496\u2013509. https:\/\/doi.org\/10.1080\/01621459.1999.10474144","journal-title":"J Am Stat Assoc"},{"key":"2904_CR32","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1056\/NEJMOA1608029\/SUPPL_FILE\/NEJMOA1608029_DISCLOSURES.PDF","volume":"375","author":"L K\u00f8ber","year":"2016","unstructured":"K\u00f8ber L, Thune JJ, Nielsen JC et al (2016) Defibrillator Implantation in patients with nonischemic systolic heart failure. N Engl J Med 375:1221\u20131230. https:\/\/doi.org\/10.1056\/NEJMOA1608029\/SUPPL_FILE\/NEJMOA1608029_DISCLOSURES.PDF","journal-title":"N Engl J Med"},{"key":"2904_CR33","doi-asserted-by":"publisher","first-page":"E895","DOI":"10.1161\/CIR.0000000000001063","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D et al (2022) 2022 AHA\/ACC\/HFSA Guideline for the management of Heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 145:E895\u2013E1032. https:\/\/doi.org\/10.1161\/CIR.0000000000001063","journal-title":"Circulation"},{"key":"2904_CR34","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/J.JCHF.2016.09.017","volume":"5","author":"A di Marco","year":"2017","unstructured":"di Marco A, Anguera I, Schmitt M et al (2017) Late Gadolinium Enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy: systematic review and Meta-analysis. JACC Heart Fail 5:28\u201338. https:\/\/doi.org\/10.1016\/J.JCHF.2016.09.017","journal-title":"JACC Heart Fail"},{"key":"2904_CR35","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/J.JACC.2008.05.058","volume":"52","author":"R Tung","year":"2008","unstructured":"Tung R, Zimetbaum P, Josephson ME (2008) A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol 52:1111\u20131121. https:\/\/doi.org\/10.1016\/J.JACC.2008.05.058","journal-title":"J Am Coll Cardiol"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-023-02904-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10554-023-02904-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-023-02904-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T06:18:47Z","timestamp":1697782727000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10554-023-02904-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,8]]},"references-count":35,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["2904"],"URL":"https:\/\/doi.org\/10.1007\/s10554-023-02904-z","relation":{"references":[{"id-type":"uri","id":"","asserted-by":"subject"}]},"ISSN":["1875-8312"],"issn-type":[{"type":"electronic","value":"1875-8312"}],"subject":[],"published":{"date-parts":[[2023,7,8]]},"assertion":[{"value":"2 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Miller receives consulting fees and research support from Pfizer. Dr White received research support from Siemens Healthineers, Circle Cardiovascular Inc., Pfizer and is a shareholder of Cohesic Inc. Dr Howarth is a shareholder of Cohesic Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Dr. Miller receives consulting fees and research support from Pfizer. Dr White received research support from Siemens Healthineers, Circle Cardiovascular Inc., Pfizer and is a shareholder of Cohesic Inc. Dr Howarth is a shareholder of Cohesic Inc.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}